Key findings from this study were that repeated perilesional human recombinant IFNα2b injections were well-tolerated and resulted in a 42% response rate in equine eyes with PSCC, with some tumors showing complete regression. The gene discussed is IFNA2; the disease is squamous cell carcinoma of penis.